TY - JOUR
T1 - Hepatitis A virus-associated fulminant hepatitis with human immunodeficiency virus coinfection
AU - Maki, Yohei
AU - Kimizuka, Yoshifumi
AU - Sasaki, Hisashi
AU - Yamamoto, Takayuki
AU - Hamakawa, Yusuke
AU - Tagami, Yoichi
AU - Miyata, Jun
AU - Hayashi, Nobuyoshi
AU - Fujikura, Yuji
AU - Kawana, Akihiko
N1 - Publisher Copyright:
© 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases
PY - 2020/2
Y1 - 2020/2
N2 - Hepatitis A virus (HAV) commonly causes acute hepatitis in humans and is transmitted through the fecal-oral route or by ingestion of contaminated food or water. HAV infection generally follows a self-limiting course; it can seldom cause fulminant hepatitis that increases the risk of mortality. To the best of our knowledge, this is the first reported fatal case of fulminant hepatitis caused by HAV in a 40-year-old male with human immunodeficiency virus (HIV) infection. The HAV genotype in this case was IA, which has recently become common globally among people living with HIV (PLWHIV), intravenous drug users, and homeless people especially in developed countries. His HIV infection was stabilized by antiretroviral drugs and his CD4 values were stable. He developed acute hepatic encephalopathy, did not respond to repeated plasma exchange therapy, and died rapidly. It is known that HIV co-infection sometimes leads to fulminant non-HAV hepatitis, although evidence supporting a correlation between fulminant hepatitis A risk and HIV infection is still lacking. This case demonstrated the fatal risk of HAV infection in PLWHIV; it was suggested that education about appropriate preventive measures and vaccination are important for preventing HAV infections among PLWHIV.
AB - Hepatitis A virus (HAV) commonly causes acute hepatitis in humans and is transmitted through the fecal-oral route or by ingestion of contaminated food or water. HAV infection generally follows a self-limiting course; it can seldom cause fulminant hepatitis that increases the risk of mortality. To the best of our knowledge, this is the first reported fatal case of fulminant hepatitis caused by HAV in a 40-year-old male with human immunodeficiency virus (HIV) infection. The HAV genotype in this case was IA, which has recently become common globally among people living with HIV (PLWHIV), intravenous drug users, and homeless people especially in developed countries. His HIV infection was stabilized by antiretroviral drugs and his CD4 values were stable. He developed acute hepatic encephalopathy, did not respond to repeated plasma exchange therapy, and died rapidly. It is known that HIV co-infection sometimes leads to fulminant non-HAV hepatitis, although evidence supporting a correlation between fulminant hepatitis A risk and HIV infection is still lacking. This case demonstrated the fatal risk of HAV infection in PLWHIV; it was suggested that education about appropriate preventive measures and vaccination are important for preventing HAV infections among PLWHIV.
KW - Fulminant hepatitis
KW - Hepatitis A virus (HAV)
KW - Human immunodeficiency virus (HIV)
KW - Sexually transmitted disease
UR - http://www.scopus.com/inward/record.url?scp=85072292956&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072292956&partnerID=8YFLogxK
U2 - 10.1016/j.jiac.2019.08.010
DO - 10.1016/j.jiac.2019.08.010
M3 - Article
C2 - 31543437
AN - SCOPUS:85072292956
SN - 1341-321X
VL - 26
SP - 282
EP - 285
JO - Journal of Infection and Chemotherapy
JF - Journal of Infection and Chemotherapy
IS - 2
ER -